GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Amedisys Inc (STU:ADY) » Definitions » Cyclically Adjusted Revenue per Share

Amedisys (STU:ADY) Cyclically Adjusted Revenue per Share : €57.60 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Amedisys Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Amedisys's adjusted revenue per share for the three months ended in Mar. 2024 was €15.940. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €57.60 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Amedisys's average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 4.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Amedisys was 17.80% per year. The lowest was 1.00% per year. And the median was 5.95% per year.

As of today (2024-05-15), Amedisys's current stock price is €87.00. Amedisys's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €57.60. Amedisys's Cyclically Adjusted PS Ratio of today is 1.51.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Amedisys was 6.21. The lowest was 0.28. And the median was 1.47.


Amedisys Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Amedisys's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amedisys Cyclically Adjusted Revenue per Share Chart

Amedisys Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.95 39.59 48.11 54.43 55.72

Amedisys Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.00 55.75 58.12 55.72 57.60

Competitive Comparison of Amedisys's Cyclically Adjusted Revenue per Share

For the Medical Care Facilities subindustry, Amedisys's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amedisys's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Amedisys's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Amedisys's Cyclically Adjusted PS Ratio falls into.



Amedisys Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Amedisys's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=15.94/129.4194*129.4194
=15.940

Current CPI (Mar. 2024) = 129.4194.

Amedisys Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 6.887 100.560 8.864
201409 7.075 100.428 9.117
201412 7.336 99.070 9.583
201503 8.511 99.621 11.057
201506 8.366 100.684 10.754
201509 8.649 100.392 11.150
201512 9.356 99.792 12.134
201603 9.348 100.470 12.041
201606 9.525 101.688 12.123
201609 9.526 101.861 12.103
201612 9.744 101.863 12.380
201703 10.007 102.862 12.591
201706 9.721 103.349 12.173
201709 9.124 104.136 11.339
201712 9.761 104.011 12.145
201803 9.361 105.290 11.506
201806 10.308 106.317 12.548
201809 10.941 106.507 13.295
201812 11.612 105.998 14.178
201903 12.574 107.251 15.173
201906 13.248 108.070 15.865
201909 13.609 108.329 16.258
201912 13.602 108.420 16.236
202003 13.389 108.902 15.912
202006 12.941 108.767 15.398
202009 13.888 109.815 16.367
202012 13.606 109.897 16.023
202103 13.594 111.754 15.743
202106 14.198 114.631 16.030
202109 14.300 115.734 15.991
202112 15.080 117.630 16.591
202203 15.110 121.301 16.121
202206 16.149 125.017 16.718
202209 17.279 125.227 17.858
202212 16.290 125.222 16.836
202303 15.920 127.348 16.179
202306 15.666 128.729 15.750
202309 15.875 129.860 15.821
202312 16.038 129.419 16.038
202403 15.940 129.419 15.940

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Amedisys  (STU:ADY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Amedisys's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=87.00/57.6
=1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Amedisys was 6.21. The lowest was 0.28. And the median was 1.47.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Amedisys Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Amedisys's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Amedisys (STU:ADY) Business Description

Industry
Traded in Other Exchanges
Address
3854 American Way, Suite A, Baton Rouge, LA, USA, 70816
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Amedisys (STU:ADY) Headlines

No Headlines